Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Net Cash Flow (2020 - 2025)

Definitive Healthcare (DH) has disclosed Net Cash Flow for 6 consecutive years, with $55.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 275.09% year-over-year to $55.2 million, compared with a TTM value of $56.9 million through Dec 2025, up 327.8%, and an annual FY2025 reading of $56.9 million, up 327.8% over the prior year.
  • Net Cash Flow was $55.2 million for Q4 2025 at Definitive Healthcare, up from $27.4 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $197.8 million in Q4 2021 and bottomed at -$157.6 million in Q1 2022.
  • Average Net Cash Flow over 5 years is $6.9 million, with a median of $2.9 million recorded in 2021.
  • The sharpest move saw Net Cash Flow skyrocketed 2067.64% in 2021, then plummeted 9475.09% in 2023.
  • Year by year, Net Cash Flow stood at $197.8 million in 2021, then tumbled by 141.23% to -$81.6 million in 2022, then surged by 165.05% to $53.1 million in 2023, then crashed by 159.38% to -$31.5 million in 2024, then surged by 275.09% to $55.2 million in 2025.
  • Business Quant data shows Net Cash Flow for DH at $55.2 million in Q4 2025, $27.4 million in Q3 2025, and -$25.6 million in Q2 2025.